GOULD ROBERT J (See Remarks) sold 3.2% of their position (15K shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $160.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-037573
DirectorOfficer10% Owner· See Remarks
Since Jul 2019
-15K
Net shares
Net seller
$160.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$10.72
Trade value
$160.86K
% of position
3.2%
2/2/2026
469.86K→454.86K
Total
Net shares
−15K
Net value
-$160.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −15K | $10.72 | $160.86K | 3.2% | 469.86K | 454.86K |
| Total | −15K | -$160.86K | ||||||
Derivative Transactions0
No derivative transactions reported